Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotini

Tytuł :
Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotini
Autorzy :
Chen HF
Zhang QX
Zhu YC
Du KQ
Li XF
Wu LX
Wang WX
Xu CW
Pokaż więcej
Temat :
lung adenocarcinoma
ROS1
crizotinib
metastasis
small intestine
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło :
OncoTargets and Therapy, Vol Volume 11, Pp 7821-7825 (2018)
Wydawca :
Dove Medical Press, 2018.
Rok publikacji :
2018
Kolekcja :
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Typ dokumentu :
article
Opis pliku :
electronic resource
Język :
English
ISSN :
1178-6930
Relacje :
https://www.dovepress.com/intestinal-metastasis-from-primary-ros1-positive-lung-adenocarcinoma-c-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930
Dostęp URL :
https://doaj.org/article/6320fe0aa75e46eab7e5f8ef52ee8a00
Numer akcesji :
edsdoj.6320fe0aa75e46eab7e5f8ef52ee8a00
Czasopismo naukowe
Hua-fei Chen,1,* Qu-xia Zhang,2,* You-cai Zhu,1 Kai-qi Du,1 Xiao-feng Li,1 Li-xin Wu,1 Wen-xian Wang,3 Chun-wei Xu2 1Department of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China; 2Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China; 3Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China *These authors contributed equally to this work Abstract: Small intestinal metastases from primary lung cancer are rare. Such patients have a poor prognosis. Early diagnosis of small intestinal metastases is difficult because of the low incidence of clinically apparent symptoms. The standard treatment for small intestinal metastases has not been established. A 69-year-old Chinese man presented for evaluation of a tumor in the right lower lung and mediastinal lymph node enlargement on clinical examination. The clinical stage was cT2N2M0 (stage IIIA). Histologic examination of the tumor revealed lung adenocarcinoma. He could not tolerate surgery; hence, he received two chemotherapy regimens. However, the disease progressed. He had bloating after chemotherapy and decreased flatus. An abdominal CT scan showed an intestinal effusion with local intestinal obstruction. Medical treatment was ineffective; hence, he underwent a diagnostic laparoscopy. The pathologic evaluation suggested an intestinal metastatic adenocarcinoma from the primary lung cancer. Based on an real-time PCR assay, the tumor had a ROS1 fusion and responded well to crizotinib. The progression-free survival was 7 months. Physicians must be aware of the possibility of intestinal metastases from primary lung cancer. With an accurate diagnosis and thorough evaluation, patients may benefit from targeted therapy. Keywords: lung adenocarcinoma, ROS1, crizotinib, metastasis, small intestine

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies